Françoise May-Levin
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
Papers in
- Oncology 26
- HER2/EGFR in Cancer Research 10
- Cancer Treatment and Pharmacology 7
- Bone health and treatments 3
-
- Breast Cancer Treatment Studies 14
- Co-authors
- H Mouriesse (20 shared papers)G Contesso (17 shared papers)Rodrigo Arriagada (5 shared papers)D Sarrazin (3 shared papers)F Fontaine (3 shared papers)Daniel H. Clarke (2 shared papers)M. Spielmann (7 shared papers)Jean‐Paul Travagli (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (3 papers)Journal of Clinical Oncology (3 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)British Journal of Cancer (3 papers)International Journal of Cancer (3 papers)
- Partner nations
- FranceDenmarkNetherlands
In The Last Decade
Françoise May-Levin
43 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 75
- Cancer Research 670
- Oncology 636
- Pathology and Forensic Medicine 296
- Genetics 157
- Geriatrics and Gerontology 18
Countries citing papers authored by Françoise May-Levin
This map shows the geographic impact of Françoise May-Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise May-Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise May-Levin more than expected).
Fields of papers citing papers by Françoise May-Levin
This network shows the impact of papers produced by Françoise May-Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise May-Levin. The network helps show where Françoise May-Levin may publish in the future.
Co-authors
The 25 scholars most cited alongside Françoise May-Levin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1985 | 370 | |
| 2 | 1986 | 122 | |
| 3 | 1987 | 117 | |
| 4 | 1994 | 91 | |
| 5 | 1988 | 55 | |
| 6 | Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast. | 1991 | 53 |
| 7 | 1990 | 52 | |
| 8 | 2014 | 52 | |
| 9 | 1994 | 51 | |
| 10 | 1981 | 44 | |
| 11 | 1984 | 41 | |
| 12 | 1994 | 31 | |
| 13 | 1992 | 30 | |
| 14 | 1986 | 28 | |
| 15 | Phase II study of elliptinium in advanced breast cancer. | 1985 | 27 |
| 16 | A new approach allowing an early prognosis in breast cancer: the ratio of estrogen receptor (ER) ligand binding activity to the ER-specific mRNA level. | 1989 | 26 |
| 17 | 1990 | 22 | |
| 18 | 2012 | 21 | |
| 19 | 1988 | 17 | |
| 20 | 1995 | 17 |
About Françoise May-Levin
Françoise May-Levin is a scholar working on Oncology, Cancer Research, Genetics, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 43 papers that have together received 1.4k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (14 papers), Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (10 papers), Cancer Treatment and Pharmacology (7 papers), Breast Lesions and Carcinomas (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Bone health and treatments (3 papers). The work is most often cited by research in Cancer Research (670 citations), Oncology (636 citations), Pathology and Forensic Medicine (296 citations), Genetics (157 citations) and Geriatrics and Gerontology (18 citations). Françoise May-Levin has collaborated with scholars based in France, Denmark and Netherlands. Frequent co-authors include H Mouriesse, G Contesso, Rodrigo Arriagada, D Sarrazin, F Fontaine, Daniel H. Clarke, M. Spielmann, Jean‐Paul Travagli, Monique G. Lê and Jean-Claude Delarue. Their work appears in journals such as Breast Cancer Research and Treatment, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, British Journal of Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.